Takeda Pharmaceutical Co Ltd (TKPHF) FCF Payout Ratio (2018 - 2026)
Takeda Pharmaceutical (TKPHF) posted quarterly FCF Payout Ratio of 0.83 for Q2 2026, down 49.97% year-over-year from 1.65 in Q2 2025, and up 92.12% quarter-over-quarter from 10.5 in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) FCF Payout Ratio (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's FCF Payout Ratio history runs 9 years deep, the most recent figure standing at 0.83 for Q2 2026.
- In Q2 2026, FCF Payout Ratio fell 49.97% year-over-year to 0.83; the TTM figure through Jun 2026 stood at 0.31 (down 1.31% YoY), while the FY2026 annual figure was 0.3, down 15.12% from the prior year.
- FCF Payout Ratio for Q2 2026 stood at 0.83, up from 10.5 in the prior quarter.
- The five-year high for FCF Payout Ratio was 11.37 in Q1 2023, with the low at 20.42 in Q1 2024.
- The 5-year median for FCF Payout Ratio is 0.46 (2025), against an average of 1.47.
- The sharpest annual moves came in 2023 and 2024: FCF Payout Ratio soared 235.87% in 2023, then plunged 279.6% in 2024.
- Takeda Pharmaceutical's FCF Payout Ratio stood at 0.31 in 2022, then sank by 128.0% to 0.71 in 2023, then jumped by 52.52% to 0.34 in 2024, then declined by 5.91% to 0.36 in 2025, then plunged by 130.36% to 0.83 in 2026.
- Business Quant data shows TKPHF's FCF Payout Ratio at 0.83 in Q2 2026, 10.5 in Q1 2026, and 0.36 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.83 |
| Mar 31, 2026 | -10.50 |
| Dec 31, 2025 | -0.36 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -4.56 |
| Dec 31, 2024 | -0.34 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.61 |
| Mar 31, 2024 | -20.42 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.01 |
| Jun 30, 2023 | -0.94 |
| Mar 31, 2023 | -3.57 |
| Dec 31, 2022 | -0.31 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -1.02 |
| Mar 31, 2022 | 3.38 |
| Dec 31, 2021 | -0.35 |
| Sep 30, 2021 | -0.04 |